Business
Reliance Global Group Announces Strategic Launch of Scale51 Operating Model Through EZRA International Group
Company Outlines Next Phase of Growth Focused on Control Acquisitions Designed to Scale Breakthrough Technology Platforms LAKEWOOD, NJ, Feb. 04, 2026 (GLOBE
About this update from Reliance Global Group, Inc.
[{"type":"text","content":"Company Outlines Next Phase of Growth Focused on Control Acquisitions Designed to Scale Breakthrough Technology Platforms\nLAKEWOOD, NJ, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Reliance Global Group, Inc. (Nasdaq: EZRA) (the “Company”) today announced a strategic advancement designed to position the Company for its next phase of growth, expanding on its InsurTech foundation through the launch of Scale51, an operating and acquisition model within its newly established subsidiary, EZRA International Group. The Company believes that Scale51 represents an expansion beyond the Company’s InsurTech foundation and is intended to acquire controlling stakes (51%) in technology companies and to support their scaling through U.S. market execution. Under this expanded strategy, the Company intends to continue operating and optimizing its InsurTech platforms and insurance brokerage businesses as an operational and cash flow foundation that the Company believes can support its expanded strategy. Through Scale51, the Company plans to acquire majority ownership positions in high-potential, technology-driven businesses and actively support their growth across sectors including Artificial Intelligence and Data Analytics; Cybersecurity, FinTech and InsurTech; as well as MedTech and Digital Health. Scale51 is a growth platform focused on hands-on operational execution and milestone-driven value creation. The Company believes this model enables alignment across governance, execution, and capital allocation, while leveraging its public company infrastructure and operating expertise to support portfolio companies at critical stages of development. For shareholders, Scale51 is designed to create long-term value by taking control positions in high-potential technology companies and actively driving their execution and scaling within the U.S. market. The Company’s recently announced potential transactions with Enquantum Ltd., a cybersecurity company developing post-quantum encryption and next-generation data protection technologies and Scentech Medical, an Israeli AI-driven diagnostics company focused on early disease detection using non-invasive, breath-based disease detection technology. which are currently expected to be among the first anticipated transactions under the Scale51 business model. Each such transaction remains subject to completion of tradition...